نتایج جستجو برای: azelnidipine

تعداد نتایج: 144  

Journal: :Biological and Pharmaceutical Bulletin 2008

2014
Kazi Rafiq Akira Nishiyama Yoshio Konishi Takashi Morikawa Chizuko Kitabayashi Masakazu Kohno Tsutomu Masaki Hirohito Mori Hiroyuki Kobori Masahito Imanishi Jaap A. Joles

A growing body of evidence indicates that renal tissue injuries are reversible. We investigated whether dietary salt reduction with the combination therapy of angiotensin II type 1 receptor blocker (ARB) plus calcium channel blocker (CCB) reverses renal tissue injury in Dahl salt-sensitive (DSS) hypertensive rats. DSS rats were fed a high-salt diet (HS; 4% NaCl) for 4 weeks. Then, DSS rats were...

2011
Hidenori Yoshii Tomoya Mita Junko Sato Yuuki Kodama Jong Bock Choi Koji Komiya Kazuhisa Matsumoto Rei Kanno Masahiko Kawasumi Hajime Koyano Takahisa Hirose Tomio Onuma Ryuzo Kawamori Hirotaka Watada

UNLABELLED Aims/Introduction:  Angiotensin II type 1 receptor blockers (ARB) are regarded as first-line treatment for type 2 diabetes with hypertension. However, lowering blood pressure to the target level often requires more than one antihypertensive agent as recommended by the guideline. In this open-label, prospective, crossover clinical trial, we compared the effects of combination treatmen...

Journal: :World Journal of Biology Pharmacy and Health Sciences 2023

A simple, specific, accurate and precise spectrophotometric method was developed validated for simultaneous estimation of Azelnidipine Valsartan in Synthetic Mixture. The wavelength 240.00 nm 250.00 nm. Beer’s law is obeyed the concentration range 2-10μg/ml 16-80μg/ml correlation coefficient 0.9999 0.9993 respectively. % recovery were found to be 101.2 - 101.9 101.8 Intraday precision 0.06 – 0....

Journal: :Biological & pharmaceutical bulletin 2008
Tomomi Kurashige Katsushige Abe Akira Furusu Masanobu Miyazaki Yoko Obata Zihyin Xia Masayuki Nakazawa Yuka Nakazawa Satoshi Funakoshi Takashi Harada Takehiko Koji Shigeru Kohno

To assess whether azelnidipine (AZN) exerts renoprotective effects, 20-week-old adult male stroke-prone spontaneously hypertensive rats (SHRsp) were treated with AZN 10 mg/kg/d (n=6), olmesartan (OLM) 3 mg/kg/d (n=4), hydralazine (HYD) 20 mg/kg/d (n=3), or water (control; n=5). Each test agent was administered by oral gavage for 12 weeks. Systolic blood pressure (SBP) was measured every 2 weeks...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید